Michael Learner
maps bulletin - volume xiv - number 1 - summer 2004
< Return to Table of Contents

A Cross-Cultural Comparison of Values, Beliefs, and Sense of Coherence in Psychedelic Drug Users Summary of findings from a MAPS-funded study

Micheal Lyvers, Ph.D.

Past research has linked the use of psychedelic substances to profound spiri- tual change (Pahnke 1966; Doblin 1991). In a high-dose psychedelic experience, users may claim to encounter God, to merge with the cosmos or undergo death and rebirth. Reports from many users resemble Buddhist or Hindu descriptions of self-realization, satori or enlightenment. This mystical experience is said to have a universal aspect that transcends cultural context. If psyche- delic drugs can produce mystical experi- ences, then the values and beliefs of psyche- delic users should differ in crucial respects from those expressed by users of other illicit drugs such as cocaine or heroin. Further, the values and beliefs of psychedelic users should be similar across different cultures. The present study tested these hypotheses by examining different types of drug users in Israel and Australia, specifically compar- ing the values, beliefs and sense of coher- ence (an index of physical and mental well- being) of users of psychedelic drugs with users of non-psychedelic illicit drugs (marijuana, heroin, cocaine, etc.), and with non-users of illegal drugs.

Method & Subjects

Participants were considered to have had a psychedelic experience if they reported at least one high-dose "trip" or "overwhelming experience" on a psychedelic drug. A total of 183 subjects participated in the study. Participants included 41 Israeli psychedelic users and 47 Australian psychedelic users (a total of 88). Other illegal drug users included 18 Israelis and 11 Australians (a total of 29). The non-users of illegal drugs were 51 Israelis and 15 Australians (a total of 66). Groups were divided on the basis of the Drug Use Questionnaire (DUQ) responses indicating history of substance use.

Materials

Life Values Inventory (LVI; Crace & Brown 1996): measures 14 core life values, or global orientations that influence behavior and decision making. Sense of Coherence Scale (SOCS; Antonovsky 1987): measures the health- related ability to cope with life stress in terms of the cognitive dimensions of comprehensibility, manageability, and meaningfulness.

Mystical Beliefs Questionnaire (MBQ; derived from Pahnke 1966): uses 4-point Likert scales (a measurement method that allows answers ranging from "strongly disagree" to "strongly agree") to rate mystical beliefs such as a universal soul, a spiritual or transcendental dimension to existence, and oneness with God, nature, and the universe.

Emotional Empathic Tendency Scale (EETS; Mehrabian 1994): measures one's ability to feel and identify another's emo- tions.Drug Use Questionnaire: assesses use of illegal drugs such as marijuana, MDMA, cocaine, amphetamine, heroin/opiates, and psychedelics (LSD, mushrooms/psilocybin, peyote/mescaline, etc.) as well as demo- graphic information.

Procedure

Participants were recruited by notices posted in areas frequented by drug users, and by word of mouth (snow- ball method), in Israel (Tel Aviv, Haifa, Jerusalem) and Australia (Nimbin, Byron Bay, Melbourne, Gold Coast). Interested drug users contacted the researchers, who sent them a questionnaire packet and a self-addressed stamped envelope for return of the completed forms. Any incom- plete forms that were received were discarded.

If psychedelic drugs can produce mystical experiences, then the of psychedelic users should differ in crucial respects from those expressed by users of other illicit drugs such as cocaine or heroin.

Discussion

Findings were largely consistent with predictions. The main finding was that regardless of culture of origin, users of psychedelic drugs had higher scores than users of other illegal drugs and non-users of illegal drugs on the MBQ, a measure of mystical beliefs such as "oneness with the cosmos" and a belief in the "divine within." Effect size in this analysis was high (.46) suggesting a strong degree of association between psychedelic use and MBQ scores. These results are consistent with the findings of Pahnke (1966) and Doblin (1991) of a profound and lasting spiritual influence of the psychedelic experience. Users of psychedel- ics also scored higher than other illegal drug users on life values thought to be associated with spiritual or mystical beliefs, such as concern for environment, concern for others, creativity, and spirituality. In addition, psychedelic drug users scored significantly lower on financial prosperity than both control groups. Surprisingly, none of the measures differentiated Israelis from Australians.

Additional support was reflected in the empathy questionnaire (EETS) findings that psychedelic drug users reported significantly higher levels of empathetic tendencies than both other illegal drug users and non-users of illegal drugs. Inter- estingly, data analysis revealed that both illegal drug user groups were more empathetic than non-users of illegal drugs. The present results suggest that the effects of psychedelic drugs may be more impor- tant than the cultural differences between Israel and Australia in influencing the life values and spiritual beliefs of drug users in these two countries. Contemporary research has suggested that psychedelic experiences can modify one's worldview, produce long- lasting changes in personal beliefs, and can be responsible for personal transformations that alter the future conduct of one's life (Shanon 2003).

If the psychedelic mystical experience does induce lasting positive changes in attitude and behavior, it was hypothesized that differences would be evident in the psychedelic drug user's subjective sense of health and well-being. Evidence of such differences was obtained in the present study. A score on the SOC scale is assumed by Antonovsky (1987) to reflect one's position on the health-illness continuum in terms of both physical and mental health. The higher a subjects' SOC score, the more available are resources to deal with life stressors that can affect our physical and mental health (Antonovsky 1987). Psychedelic users were characterized by significantly higher levels of meaningfulness (one of the three SOC sub-scales) than both the other illegal drug user group and the non-user group. In addition, psychedelic drug users exhibited significantly higher scores on manageability and on the total scale than the other illegal drug user group. The findings suggest that psychedelic users perceive life as more meaningful than other illegal drug users and non- users of illegal drugs, consistent with the assumption of a profound mystical experience.

There are two competing explanations for such profound differences in life values and beliefs between groups in the present study. It is possible that the higher levels of spirituality and associated values in psychedelic users were due to inherent pre-drug spiritual tendencies. If psychedelic users were more spiritually inclined to begin with (that is, pre-drug), then psychedelic drug use may be seen as a by-product of such an orientation rather than the cause of a change in values. Alternatively, previous experimental findings suggest that the psychedelic experience itself can reshape values and beliefs (Doblin 1991; Pahnke 1966; Shanon 2003). According to this view, such changes in values and beliefs stem from a subjectively real, vivid, and transformative experience. The "God within," cosmic unity, and other concepts associated with such states of mind are often dismissed as sub-cultural slogans that have nothing to do with reality. Yet the similarity in values and understanding between people from vastly different backgrounds who have entered extreme altered states of consciousness is often striking, whether they are yogis, psyche- delic drug users, Zen Buddhists, or mystics from different religions. Different metaphors are used to describe what may be the same inner journey of the soul. Accordingly, many religious figures and psychedelic seekers who experienced those realms of consciousness may speak the same inner truth. *

References

Antonovsky, A. (1987). Unraveling the mystery of health: How people manage stress and stay well. San Francisco, CA: Jossey-Bass.

Crace, R.K. & D. Brown (1996). Life values inventory. Ann Arbor, MI: Aviat Publishing.

Doblin, R. (1991). Pahnke's "Good Friday Experiment": A long-term follow-up and methodological critique. Journal of Transpersonal Psychology 23(1): 1-28.

Mehrabian, A. (1994). Manual for Emotional Empathic Tendency Scale (EETS).

Pahnke, W. (1966). "The contribution of the psychology of religion to the therapeutic use of psychedelic substances." In H. Abramson (ed.), The use of LSD in psychotherapy and alcoholism (pp. 629-649). New York: Bobbs-Merrill.

Shanon, B. (2003). Hallucinations. Journal of Consciousness Studies 10(2): 3-31.

 
 
< Return to Table of Contents: Summer 2004 Issue - "10 stamps and $250,000"
 
Spring 2010 Vol. 20, No. 1 Special Edition: Psychedelics, Death and Dying
Autumn 2009 Vol. 19, No. 3 MAPS Financial Report: Fiscal Year 2008-09
Summer 2009 Vol. 19, No. 2 MAPS Research Update 2009
Spring 2009 Vol. 19, No. 1 Special Edition: Psychedelics and Ecology
Winter 2008/09 Vol. 18, No. 3 MAPS 2008 Financial Report
Summer 2008 Vol. 18, No. 2 Phoenix Rising: A Review of MAPS Research
Spring 2008 Vol. 18, No. 1 Special Edition: Technology and Psychedelics
Winter 2007 Vol. 17, No. 3 MAPS 06-07 Fiscal Yearly Report
Autumn 2007 Vol. 17, No. 2 Special Edition: Psychedelics and Self-Discovery
Spring/Summer 2007 Vol. 17, No. 1 The Chrysalis Stage
Winter 2006-7 Vol. 16, No. 3 Low Maintenance/High Performance
Autumn 2006 Vol. 16, No. 2 Technologies of Healing
Spring 2006 Vol. 16, No. 1 MAPS' 20th Anniversary
Winter 2005 Vol. 15, No. 3 MAPS final year as a teenager
Summer 2005 Vol. 15, No. 2 Israel Conference: MDMA/PTSD Research
Spring 2005 Vol. 15, No. 1 Accelerating flow of work and time
Autumn 2004 Vol. 14, No. 2 Rites of Passage: Kids and Psychedelics
Summer 2004 Vol. 14, No. 1 10 stamps and $250,000
Winter 2003 Vol. 13, No. 2 Holy Fire
Spring 2003 Vol. 13, No. 1 60th Anniversary of the Discovery of LSD
Autumn 2002 Vol. 12, No. 3 Vision
Summer 2002 Vol. 12, No. 2 "From celebration to frustration, and back again."
Spring 2002 Vol. 12, No. 1 Sex, Spirit & Psychedelics 2002
Autumn 2001 Vol. 11, No. 2 "In the future, it will be called Despair."
Spring 2001 Vol. 11, No. 1 "A Tidal Wave of Ecstasy!"
Autumn 2000 Vol. 10, No. 3 Creativity 2000
Summer 2000 Vol. 10, No. 2 Endings and Beginnings
Spring 2000 Vol. 10, No. 1 Making History in Slow Motion
Winter 1999/00 Vol. 9, No. 4 To the Ends of the Earth for MDMA Research...
Autumn 1999 Vol. 9, No. 3 MAPS' long-standing efforts to conduct...
Summer 1999 Vol. 9, No. 2 MAPS has come full circle...
Spring 1999 Vol. 9, No. 1 Patience, persistence and passion
Winter 1998/99 Vol. 8, No. 4 One of special pleasures of directing MAPS...
Autumn 1998 Vol. 8, No. 3 The Ayahuasca Issue (with Hofmann interview)
Summer 1998 Vol. 8, No. 2 Emotionally Powerful Anecdotes...
Spring 1998 Vol. 8, No. 1 Death Has a Way of Focusing One's Attention
Autumn 1997 Vol. 7, No. 4 Celebration is in Order
Summer 1997 Vol. 7, No. 3 Time Horizons
Spring 1997 Vol. 7, No. 2 Synchronicity
Winter 1996/97 Vol. 7, No. 1 Learning to Crawl
Autumn 1996 Vol. 6, No. 4 An Invitation for Dialogue
Summer 1996 Vol. 6, No. 3 Budding Research
New Year 1996 Vol. 6, No. 2 Sending Down Roots
Autumn 1995 Vol. 6, No. 1 Baby Steps
Summer 1995 Vol. 5, No. 4 Opportunity Amidst Obstacles
Winter 1994/95 Vol. 5, No. 3 Clinical Trials and Tribulations
Autumn 1994 Vol. 5, No. 2 Building Towards Clinical Trials
Summer 1994 Vol. 5, No. 1 Politics and Protocols: In Search of a Balance
Spring 1994 Vol. 4, No. 4 Laying the Groundwork
Winter 1993/94 Vol. 4, No. 3 A Time of Tests
Summer 1993 Vol. 4, No. 2 So Close Yet So Far
Spring 1993 Vol. 4, No. 1 Remembrance and Renewal
Winter 1992/93 Vol. 3, No. 4 Forging New Alliances
Summer 1992 Vol. 3, No. 3 Building on Common Ground
Spring 1992 Vol. 3, No. 2 Small Steps, Gradual Progress, New Opportunities
Winter 1991/92 Vol. 3, No. 1 The Rekindling of a Thousand Points of Light
Summer 1991 Vol. 2, No. 2 MDMA protocol development with cancer patients
Winter 1990/91 Vol. 2, No. 1 MAPS' Swiss pharmacologically-assisted psychotherapy conference
Autumn 1990 Vol. 1, No. 3 What and Who is MAPS?
Summer 1989 Vol. 1, No. 2 Switzerland Leads the Way
Summer 1988 Vol. 1, No. 1 MDMA can become a legal medicine